Physician

Eugene Chung, M.D.

According to 2025 Medicare claims, Eugene Chung, M.D. (NPI: 1003893926) practices advanced heart failure and transplant cardiology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC (NPI: 1497901458; TIN: 263070266) and primary practice location at 45219-2906. Chung is affiliated with the Kettering Physician Partners Accountable Care LLC (ACO ID: A5062) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Chung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 768 traditional Medicare patients, billed 1,665 HCPCS/CPT codes, and received $86,158 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,637 prescription claims across 475 beneficiaries totaling $1,377,814 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 33 claims. Open Payments data shows 92 records totaling $155,108. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $198,763 to $86,158. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $364,560 to $1,377,814. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $3,282 and ending at $3,852.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,247	3,085	$198,763
2016	1,326	3,204	$210,803
2017	1,138	3,038	$200,394
2018	1,027	2,658	$170,884
2019	916	2,520	$171,711
2020	849	2,215	$155,971
2021	854	2,020	$136,232
2022	677	1,338	$75,941
2023	522	1,251	$75,167
2024	768	1,665	$86,158

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	808	8,335	$364,560
2016	890	8,161	$426,307
2017	1,044	7,959	$561,622
2018	971	7,099	$643,142
2019	946	7,072	$754,555
2020	917	7,489	$952,674
2021	945	7,518	$1,274,063
2022	883	6,315	$1,459,409
2023	606	3,752	$1,239,591
2024	475	3,637	$1,377,814

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	56	$2,310
2016	N/R	87	$3,734
2017	N/R	212	$12,287
2018	N/R	250	$17,722
2019	N/R	133	$6,806
2020	N/R	155	$13,551
2021	N/R	218	$13,700
2022	N/R	31	$2,093
2023	N/R	33	$2,506
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	60	131	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	273	$87
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	182	183	$46
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	154	168	$5
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	115	121	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	365	22,256	$426,921
Entresto	Sacubitril/Valsartan	356	19,109	$388,553
Eliquis	Apixaban	217	9,872	$193,661
Farxiga	Dapagliflozin Propanediol	78	3,760	$67,272
Xarelto	Rivaroxaban	62	2,700	$50,308

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$35,158	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$119,950	Edwards Lifesciences Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eugene Chung, M.D.?

Tedicare shows public-source Medicare data for Eugene Chung, M.D. (NPI 1003893926), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eugene Chung, M.D. have ACO affiliation data?

Eugene Chung, M.D. is shown with ACO affiliation data for Kettering Physician Partners Accountable Care LLC (MSSP, ACO ID A5062) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Eugene Chung, M.D.?

Eugene Chung, M.D. is linked to THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC (billing NPI 1497901458) in the available physician profile data.

Does Eugene Chung, M.D. have Open Payments data?

Eugene Chung, M.D. has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.